1.A Case of Immunoglobulin E Mediated Anaphylaxis to Levodropropizine.
Kyung Hee PARK ; Il Seon YUN ; Soo Young CHOI ; Jae Hyun LEE ; Chein Soo HONG ; Jung Won PARK
Yonsei Medical Journal 2013;54(1):262-264
We experienced a case of immunoglobulin E (IgE) mediated anaphylaxis to levodropropizine. The patient was an 18-year old Korean woman. After taking the common cold medication including acetaminophen, domperidone, and levodropropizine, skin rash, angioedema and anaphylaxis were developed immediately. As she was tolerable to acetaminophen alone, we thought the culprit agent was maybe a levodropropizine tablet. To confirm the culprit, she underwent skin prick test and oral drug provocation test with the suspected one. Finally we detected levodropropizine specific IgE and confirmed the specificity by inhibition enzyme-linked immunosorbent assay (ELISA).
Adolescent
;
Anaphylaxis/*chemically induced/*immunology
;
Antitussive Agents/*adverse effects
;
Bronchial Provocation Tests
;
Enzyme-Linked Immunosorbent Assay
;
Female
;
Humans
;
Immunoglobulin E/*immunology
;
Propylene Glycols/*adverse effects
;
Skin Tests
2.Levodropropizine-Induced Anaphylaxis: Case Series and Literature Review.
Jae Won SONG ; Young Sook JANG ; Moon Chan JUNG ; Joo Hee KIM ; Jeong Hee CHOI ; Sunghoon PARK ; Yong Il HWANG ; Seung Hun JANG ; Ki Suck JUNG
Allergy, Asthma & Immunology Research 2017;9(3):278-280
Levodropropizine is commonly used as an antitussive drug for acute and chronic cough. It is a non-opioid agent with peripheral antitussive action via the modulation of sensory neuropeptide levels in the airways. Thus, levodropropizine has a more tolerable profile than opioid antitussives. However, we experienced 3 cases of levodropropizine-induced anaphylaxis. Three patients commonly presented with generalized urticaria, dyspnea, and collapse after taking cold medication including levodropropizine. To find out the culprit drug, we performed skin tests, oral provocation tests (OPTs), and basophil activation tests (BATs). Two patients were confirmed as having levodropropizine-induced anaphylaxis by OPTs, and one of them showed positive to skin prick tests (SPTs). The other patient was confirmed by skin tests and BATs. When we analyzed pharmacovigilance data related to levodropropizine collected for 5 years, most cases (78.9%) had allergic reactions, such as rash, urticaria, angioedema, and anaphylaxis. Therefore, physicians should consider that levodropropizine can be a culprit drug, when anaphylaxis occurs after taking anti-cough or common cold medication.
Anaphylaxis*
;
Angioedema
;
Antitussive Agents
;
Basophils
;
Chiroptera
;
Common Cold
;
Cough
;
Drug-Related Side Effects and Adverse Reactions
;
Dyspnea
;
Exanthema
;
Humans
;
Hypersensitivity
;
Neuropeptides
;
Pharmacovigilance
;
Skin
;
Skin Tests
;
Urticaria